Attenuation of antibody titres during 3-6 months after the second dose of the BNT162b2 vaccine depends on sex, with age and smoking as risk factors for lower antibody titres at 6 months

Yushi Nomura, Michiru Sawahata, Yosikazu Nakamura, Ryousuke Koike, Otohiro Katsube, Koichi Hagiwara, Seiji Niho, Norihiro Masuda, Takaaki Tanaka, Kumiya Sugiyama
doi: https://doi.org/10.1101/2021.11.14.21266334

Article usage

Article usage: November 2021 to October 2024

AbstractFullPdf
Nov 20213137195605
Dec 20213612985
Jan 2022126930
Feb 202277126
Mar 2022548317
Apr 202260716
May 2022541314
Jun 20226118
Jul 20223312
Aug 20224317
Sep 20225149
Oct 20225517
Nov 20224903
Dec 202244212
Jan 20233328
Feb 20232695
Mar 20232303
Apr 20233111
May 202314111
Jun 20231843
Jul 20231422
Aug 2023291113
Sep 20231577
Oct 20232323
Nov 202326134
Dec 20232433
Jan 20241854
Feb 20241915
Mar 20242014
Apr 202429113
May 202419411
Jun 202420511
Jul 202421511
Aug 20241629
Sep 20243479
Oct 2024962
Back to top
Posted November 17, 2021.
Download PDF
Data/Code
Email
Attenuation of antibody titres during 3-6 months after the second dose of the BNT162b2 vaccine depends on sex, with age and smoking as risk factors for lower antibody titres at 6 months
Yushi Nomura, Michiru Sawahata, Yosikazu Nakamura, Ryousuke Koike, Otohiro Katsube, Koichi Hagiwara, Seiji Niho, Norihiro Masuda, Takaaki Tanaka, Kumiya Sugiyama
medRxiv 2021.11.14.21266334; doi: https://doi.org/10.1101/2021.11.14.21266334
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area